LH — Laboratory of America Holdings Income Statement
0.000.00%
HealthcareBalancedLarge CapSuper Stock
- $19.33bn
- $24.35bn
- $14.88bn
- 83
- 70
- 81
- 91
Annual income statement for Laboratory of America Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 11,333 | 11,555 | 13,979 | 16,121 | 14,877 |
Cost of Revenue | |||||
Gross Profit | 3,176 | 3,253 | 4,953 | 5,624 | 4,385 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 10,008 | 10,230 | 11,476 | 12,868 | 13,103 |
Operating Profit | 1,326 | 1,325 | 2,503 | 3,253 | 1,774 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,268 | 1,105 | 2,219 | 3,127 | 1,583 |
Provision for Income Taxes | |||||
Net Income After Taxes | 929 | 825 | 1,557 | 2,380 | 1,281 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 884 | 824 | 1,556 | 2,377 | 1,279 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 884 | 824 | 1,556 | 2,377 | 1,279 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 10.2 | 9.57 | 19.5 | 25.2 | 17.1 |